SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (25714)9/23/1998 2:34:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Cheryl, You are back just in time for LGND's presentation at Bear Stearns.

P.S. Don't have any pictures and probably not prudent to post after what has happened on Yahoo!, SI, and AOL.



To: Cheryl Galt who wrote (25714)9/23/1998 3:38:00 PM
From: jayhawk969  Read Replies (2) | Respond to of 32384
 
Cheryl,

My preference is that this places a significantly different value on Ligands research for small molecules. If Bayer will pay 465MM and most is non equity what is Ligands small molecule position worth?

J.D.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News